| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 131,738 | 143,806 | 136,779 | | Cost of Revenue | 111,570 | 117,373 | 105,506 | | | Gross Profit | 20,168 | 26,433 | 31,273 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 19,423 | 19,601 | 17,581 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 745 | 6,832 | 13,692 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 168 | 2,359 | 547 | | Earnings Before Interest And Taxes | 913 | 9,191 | 14,239 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 913 | 9,191 | 14,239 | | Income Tax Expense | (282) | 104 | 1,239 | | Minority Interest |
-
| (228) | (833) | | | | Net Income From Continuing Ops | 1,195 | 8,859 | 12,167 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,195 | 8,859 | 12,167 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,195 | $8,859 | $12,167 |
|
0.10% Nasdaq 
Income Statement
